Literature DB >> 28497493

Natural and Synthetic Flavonoids as Potent Mycobacterium tuberculosis UGM Inhibitors.

Sydney A Villaume1, Jian Fu1, Inès N'Go1, Hui Liang2, Huayong Lou2, Laurent Kremer3,4, Weidong Pan2, Stéphane P Vincent1.   

Abstract

This study reports a novel class of inhibitors of uridine 5'-diphosphate (UDP) galactopyranose mutase (UGM) derived from a screening of natural products. This enzyme is an essential biocatalyst involved in the cell wall biosynthesis of Mycobacterium tuberculosis. Flavonoids are potent inhibitors of UGM. The synthesis of novel methylated flavonoids allowed a structure-activity relationship analysis to be performed and which functional groups and structural elements were required for UGM inhibition could be determined. The binding mode of one of the best inhibitors was found to be noncompetitive. Docking simulations indicated that this molecule was likely to bind UGM in its open conformation, in a cavity recently identified as a "druggable" pocket. Importantly, two of the best inhibitors of the M. tuberculosis UGM displayed moderate activity against whole M. tuberculosis cells. This study reports the first natural products that act as inhibitor of UGM. Given the importance of natural products in medicinal chemistry, these results create new opportunities for the discovery of new antitubercular agents.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  allosterism; enzymes; inhibitors; natural products; structure-activity relationships

Mesh:

Substances:

Year:  2017        PMID: 28497493     DOI: 10.1002/chem.201701812

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Antimycobacterial potentials of quercetin and rutin against Mycobacterium tuberculosis H37Rv.

Authors:  Kandasamy Sasikumar; Asit Ranjan Ghosh; Azger Dusthackeer
Journal:  3 Biotech       Date:  2018-09-28       Impact factor: 2.406

2.  Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations.

Authors:  Sherif T S Hassan; Miroslava Šudomová; Kateřina Berchová-Bímová; Shanmugaraj Gowrishankar; Kannan R R Rengasamy
Journal:  J Clin Med       Date:  2018-08-20       Impact factor: 4.241

Review 3.  Biosynthesis of Galactan in Mycobacterium tuberculosis as a Viable TB Drug Target?

Authors:  Zuzana Konyariková; Karin Savková; Stanislav Kozmon; Katarína Mikušová
Journal:  Antibiotics (Basel)       Date:  2020-01-06

4.  A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases.

Authors:  Miroslava Šudomová; Mohammad Ali Shariati; Javier Echeverría; Ioana Berindan-Neagoe; Seyed Mohammad Nabavi; Sherif T S Hassan
Journal:  Mar Drugs       Date:  2019-11-14       Impact factor: 5.118

5.  Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against Mycobacterium tuberculosis.

Authors:  Ninad V Puranik; Pratibha Srivastava; Sagar Swami; Amit Choudhari; Dhiman Sarkar
Journal:  RSC Adv       Date:  2018-03-16       Impact factor: 3.361

Review 6.  Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review.

Authors:  Ali A Rabaan; Saad Alhumaid; Hawra Albayat; Mohammed Alsaeed; Fadwa S Alofi; Mawaheb H Al-Howaidi; Safaa A Turkistani; Salah M Alhajri; Hejji E Alahmed; Abdulwahab B Alzahrani; Mutaib M Mashraqi; Sara Alwarthan; Mashael Alhajri; Fatimah S Alshahrani; Souad A Almuthree; Roua A Alsubki; Abdulmonem A Abuzaid; Mubarak Alfaresi; Mona A Al Fares; Abbas Al Mutair
Journal:  Molecules       Date:  2022-08-22       Impact factor: 4.927

7.  Identification of Aspergillus fumigatus UDP-Galactopyranose Mutase Inhibitors.

Authors:  Julia S Martin Del Campo; Meital Eckshtain-Levi; Nancy J Vogelaar; Pablo Sobrado
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.